CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults
- PMID: 20457264
- PMCID: PMC2933414
- DOI: 10.1016/j.bbmt.2010.04.015
CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults
Abstract
We undertook a prospective longitudinal study to examine humoral and cellular immune responses to influenza vaccination in hematopoietic cell transplant (HCT) patients and healthy adults. Healthy volunteers and HCT patients had blood samples taken prior to influenza vaccination and 30, 90, and 180 days postvaccination. Serum from pre- and postvaccination time points were tested for influenza A IgG and IgM by ELISA as well as tested for neutralizing antibody (NAb) titers via hemagglutination inhibition assay. Polychromatic flow cytometry was used to examine CD4(+) T cells for levels of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and CD154 (CD40 ligand) expression after stimulation with inactivated flu virus. In healthy subjects, we found a significant increase in Influenza A IgG and IgM levels as well as an increase in NAb titers pre- and post-influenza vaccination. Notably, NAb titers of most HCT patients did not rise to a protective level postvaccination. CD4(+) T cell expression of CD154 and cytokine responses were significantly reduced in HCT recipients compared to healthy adults. A lack of B cell reconstitution and dysfunctional CD4 T cell costimulation (as marked by low CD154 expression) is associated with low NAb levels postvaccination in HCT patients.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors do not have a commercial or other association that might pose a conflict of interest
Figures






Similar articles
-
Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15. Int J Infect Dis. 2012. PMID: 22704721
-
Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.Vaccine. 2016 May 5;34(21):2417-2423. doi: 10.1016/j.vaccine.2016.03.091. Epub 2016 Apr 5. Vaccine. 2016. PMID: 27055021
-
Long-term Maintenance of the Influenza-Specific Cross-Reactive Memory CD4+ T-Cell Responses Following Repeated Annual Influenza Vaccination.J Infect Dis. 2017 Mar 1;215(5):740-749. doi: 10.1093/infdis/jiw619. J Infect Dis. 2017. PMID: 28007925
-
B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination.Front Immunol. 2024 Nov 20;15:1481910. doi: 10.3389/fimmu.2024.1481910. eCollection 2024. Front Immunol. 2024. PMID: 39635527 Free PMC article.
-
Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults.Hum Vaccin Immunother. 2013 Sep;9(9):1962-70. doi: 10.4161/hv.25458. Epub 2013 Jun 27. Hum Vaccin Immunother. 2013. PMID: 23896606 Free PMC article.
Cited by
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
References
-
- Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev. 1997;157:73–78. - PubMed
-
- Ljungman P, Lewensohn-Fuchs I, Hammarstrom V, et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood. 1994;84:657–663. - PubMed
-
- Blume KG, Forman Stephen J, Appelbaum Frederick R. Thomas’ hematopoietic cell transplantation. Malden, MA: Blackwell Pub; 2004.
-
- Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 1999;94:4029–4035. - PubMed
-
- Crippa F, Holmberg L, Carter RA, et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2002;8:281–289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials